$INJ | Is Injective gearing up for another rally?
INJ is back in the spotlight amid strong developments across the Injective ecosystem, particularly in real-world assets (RWA) and institutional trading.
Key developments:
- The Canary Staked INJ ETF, trading under the ticker INJC, launched on the Nasdaq.
- The network celebrated five years since its Mainnet launch, alongside growth in trading activity and financial applications.
- The Veyra upgrade proposal includes enhancements to institutional infrastructure and cross-chain trading. Governance voting runs through November 16, with activation targeted for November 24 if approved.
Technically, INJ is trading near $8.21 after a strong rise and faces significant resistance at $8.24–$8.38. A breakout and hold above this range could open the way toward $8.60, then $8.90.
Key support levels lie around $8.05–$7.90. A drop below $7.86 would weaken the bullish outlook.
Outlook: Cautiously positive, with buying after a pullback and confirmation preferable to chasing the current rally.
$INJ — a project worth watching, but price confirmation will remain more important than the news.
This is technical analysis, not a guarantee of profit or investment advice.
INJ is back in the spotlight amid strong developments across the Injective ecosystem, particularly in real-world assets (RWA) and institutional trading.
Key developments:
- The Canary Staked INJ ETF, trading under the ticker INJC, launched on the Nasdaq.
- The network celebrated five years since its Mainnet launch, alongside growth in trading activity and financial applications.
- The Veyra upgrade proposal includes enhancements to institutional infrastructure and cross-chain trading. Governance voting runs through November 16, with activation targeted for November 24 if approved.
Technically, INJ is trading near $8.21 after a strong rise and faces significant resistance at $8.24–$8.38. A breakout and hold above this range could open the way toward $8.60, then $8.90.
Key support levels lie around $8.05–$7.90. A drop below $7.86 would weaken the bullish outlook.
Outlook: Cautiously positive, with buying after a pullback and confirmation preferable to chasing the current rally.
$INJ — a project worth watching, but price confirmation will remain more important than the news.
This is technical analysis, not a guarantee of profit or investment advice.